Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2008 by Eastern Cooperative Oncology Group.
Recruitment status was  Active, not recruiting
Information provided by:
Eastern Cooperative Oncology Group
ClinicalTrials.gov Identifier:
First received: January 12, 2004
Last updated: February 11, 2014
Last verified: October 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Kahl BS, Williams ME, Hong F, et al.: Preliminary pharmacokinetic (PK) analysis of Eastern Cooperative Oncology Group Protocol E4402: rituximab extended schedule or re-treatment trial (RESORT) . [Abstract] Blood 110 (11): A-3420, 2007.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):